Jamie Melling

Resilient (Holdings) Plc is a British company that specializes in contact centre fraud prevention, business continuity and transformation. The private company is based in London, UK and has subsidiaries in United Kingdom. The company's product, Smartnumbers, ensures that voice communications are secure, reliable and compliant.

Perpetuum Ltd. develops electromechanical vibration energy harvesting micro generators. The firm specializes in self-powered wireless sensors, wireless on-board condition monitoring for rail, rail data analytics, vibration analysis expertise, onboard train monitoring, continuous track monitoring and bogie monitoring. The company was founded in 2004 and is headquartered in Southampton, the United Kingdom.

Part of Albion Capital Group LLP, Kings Arms Yard VCT 2 Plc is a venture capital fund. The company is based in London, UK.

GyroMetric Systems Ltd. provides measurement systems for aspects of rotating shafts. Its Incremental Motion Encorder (IME) technology is used in bearing & gearbox monitoring, test rigs, torsional vibrations and torque measurement. The firm’s systems are configured to send data via a communications satellite to data storage in the cloud. Its technology is applied in the marine, energy, manufacturing and engineering industries. The company was founded in 2009 and is headquartered in Nottingham, the United Kingdom.

Part of Thales Electronics Ltd., Racal Airtech Ltd. is a British company that manufactures hardware equipment. The company is based in Bracknell, UK. Racal Airtech was acquired by Racal Electronics Plc on May 01, 1994 for $18.24 million.

Iksuda Therapeutics Ltd. operates as a biotechnology company which specializes in the development of next generation biotherapeutics. It creates new generation biological therapeutics through advanced glycosylation and conjugation technologies. The company has core expertise in protein/peptide fictionalization and glycosylation technologies, imparting improved pharmacokinetic properties to a broader range of biological therapeutics. It was founded by David John Simpson and Andrew Watts on November 21, 2007 and is headquartered in Newcastle upon Tyne, the United Kingdom.